GDashwood
TL3 Regular · Boulder, CO, US
Reads the primary literature and posts summaries with page numbers. Prefers being corrected to being agreed with.
Joined 31 August 2024 · last posted 1d
142 posts, newest first. Showing up to 150.
-
Drawing up with one needle and injecting with another Replied, post #6 · Practice › Administration · 26 Jul 2026 · 2 likes I read post #4 twice before replying, because I had assumed the opposite. Injecting slowly is worth doing for volume rather than for chemistry. Larger volumes delivered…
-
PIONEER 6 cardiovascular safety, read as a safety trial rather than an efficacy one Replied, post #9 · marked as the solution · Compounds › Oral incretins · 19 Jul 2026 · 8 likes Missed doses behave differently for a daily oral than for a weekly injection. With a short interval you are near a trough rather than perturbing a slowly moving…
-
Semaglutide and alcohol: what is actually documented Replied, post #17 · Compounds › Semaglutide · 17 Jul 2026 · 14 likes Semaglutide's structure is a modified backbone with a C18 diacid attached through a spacer. The acylation is the reason for the long half-life and it is also the reason…
-
Washout with a one-week half-life: the arithmetic — does this still hold? Replied, post #40 · Research Methods › N-of-1 designs · 13 Jul 2026 · 3 likes What I would want before treating Washout as settled: the method, the sample, and whether anyone tried to find the opposite result. Two of the three are usually missing.
-
Revisiting: Protein density versus volume when you cannot eat much Replied, post #60 · Nutrition & Training › Protein & intake · 13 Jul 2026 · 0 likes Whatever the answer on Protein density versus volume turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public,…
-
Review: a draft on reconstitution arithmetic, with objections — what changed since Replied, post #41 · Documentation › Doc review · 13 Jul 2026 · 30 likes Ask what the page would look like if it were wrong. A document with no stated failure conditions is hard to review and harder to maintain. It is a small point and it…
-
The anatomy of a question that gets answered within an hour — does this still hold? Replied, post #16 · Start Here › How to Ask · 12 Jul 2026 · 1 like A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers before you post either.
-
I joined for one answer and stayed for a year — what changed my mind Replied, post #77 · Start Here › Welcome · 12 Jul 2026 · 4 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
Seven-day rolling means and why weekly readings mislead Replied, post #15 · Outcomes › Progress reports · 12 Jul 2026 · 20 likes Taking post #14 at face value and following it one step further. If a pattern survives a rolling-mean treatment it is worth explaining. Most do not, and that is the…
-
Second pass at: Sleep apnoea improving and the equipment implications Replied, post #73 · Wellbeing › Sleep · 1 Jul 2026 · 13 likes Post #69 put the caveat in the right place and I want to underline it. Obstructive sleep apnoea: pre-existing OSA can worsen with weight before it improves…
-
Journal club: semaglutide in MASH, and surrogate endpoints Replied, post #25 · Evidence › Journal club · 30 Jun 2026 · 21 likes Adding a data point of agreement rather than a data point.
-
Aggregate verification data across the directory, with caveats Replied, post #10 · Sourcing › Independent verification · 23 Jun 2026 · 1 like Helpful, and short, which on this subject is harder than long.
-
Blinding yourself: practical methods and their limits Replied, post #36 · Research Methods › N-of-1 designs · 22 Jun 2026 · 0 likes Confirming post #33 from a second method, which matters more than confirming it from a second person. I would put moderate confidence on the mainstream reading of…
-
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #49 · Evidence › Journal club · 21 Jun 2026 · 8 likes That is consistent with mine, for whatever one more account is worth.
-
What would change my mind about repair peptides: a specific answer Replied, post #9 · Compounds › Repair & healing peptides · 12 Jun 2026 · 0 likes Taking post #8 at face value and following it one step further. Nothing in this subcategory is medical advice and several members here are describing experiments on…
-
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #68 · Compounds › Repair & healing peptides · 8 Jun 2026 · 1 like Everything in post #66 holds. The case it does not cover is the one I have. Nothing in this subcategory is medical advice and several members here are describing…
-
Why the timeline is on the right and not the left — what changed since Replied, post #48 · Meta › Site feedback · 4 Jun 2026 · 4 likes Post #47 is right about the mechanism and I think understates the practical bit. What I can speak to on timeline is narrow, so I will keep it narrow rather than…
-
Reading a home test result without over-claiming Replied, post #58 · Analytics › Home & field testing · 28 May 2026 · 4 likes Post #54 and I disagree about the size of the effect, not about the direction. Colorimetric tests: colour intensity correlates with concentration, but the relationship…
-
Official shortage notices and what they authorise Replied, post #57 · Access › Shortages · 19 May 2026 · 16 likes Adding a reference point for official shortage notices. Mine is a single case, collected without controls, and I am posting the method alongside it so it can be…
-
A supplier who responds to a discrepancy with silence — what changed since Replied, post #47 · Sourcing › Red flags · 16 May 2026 · 1 like Anonymity: a supplier that will not disclose legal name, address, or responsible person is not operating in a way that allows accountability. The conclusion is…
-
Does a peptide degrade silently, with no visual change? Replied, post #25 · Practice › Storage & stability · 11 May 2026 · 0 likes Coming back to post #21, because the follow-up matters more than the original answer. Summarising the peptide thread so far, since it is long and the answer is buried:…
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #63 · Sourcing › Logistics · 7 May 2026 · 2 likes Trying to state the Regional warehouse stock versus direct position in a way that someone who disagrees would recognise as fair, because I do not think the version in…
-
Revisiting: Primary endpoint hierarchies and why order matters Replied, post #2 · Evidence › Trials · 4 May 2026 · 0 likes Second this, and I would have said it less carefully.
-
Official shortage notices and what they authorise Replied, post #26 · Access › Shortages · 29 Apr 2026 · 1 like No disagreement from me. Posting only so the question does not look ignored.
-
Travelling with an injectable: documentation and practicalities Replied, post #23 · Access › International · 24 Apr 2026 · 30 likes Summaries lag badly in this area. Where a decision matters, read the current official document rather than a page about it, including this one.
-
A calculator that gives a right answer to the wrong question Replied, post #17 · Data & Tools › Calculators · 24 Apr 2026 · 25 likes On post #13 — agreed on the reasoning, with one qualification. Dose equivalence calculator: compounds have different potencies. The calculator is provided with a…
-
Converting between mg/mL and units per dose, both directions — the long version Replied, post #85 · Practice › Reconstitution · 23 Apr 2026 · 29 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does. I would put…
-
Risk-of-bias tools and the judgement they conceal — does this still hold? Started this topic · Evidence › Meta-analyses · 20 Apr 2026 · 29 likes Risk-of-bias tools and the judgement they conceal — does this still hold? — that is the question, and I have not found it answered plainly anywhere I have looked.…
-
Journal club: is percentage weight change the right endpoint? Replied, post #79 · Evidence › Journal club · 18 Apr 2026 · 30 likes Narrowing post #76, because the general version has more than one answer. Reading order that works for these sessions: registry entry, methods, baseline table, primary…
-
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #12 · Safety › Contraindications · 16 Apr 2026 · 1 like Adding the measurement that post #9 says would settle it. History of pancreatitis: these compounds can rarely trigger pancreatitis. History of pancreatitis increases…
-
Managing an unplanned gap in supply Replied, post #99 · Access › Shortages · 16 Apr 2026 · 7 likes Device availability and compound availability are separate supply chains and the device is frequently the constraint. I am reporting what happened, not recommending it.
-
List price versus negotiated price versus what you pay Replied, post #33 · Access › Pricing · 10 Apr 2026 · 19 likes Where I part company with post #30, and it is a narrow parting. I disagree with the framing of list price versus negotiated price above, and I think it is a substantive…
-
Prediction intervals and why they are more honest than confidence intervals Replied, post #20 · Evidence › Meta-analyses · 8 Apr 2026 · 0 likes Post #17 answers the question as asked. The question underneath it is different. The number people quote for prediction intervals is a central estimate presented…
-
Why this subcategory is stricter about sourcing than most Replied, post #16 · Compounds › Secretagogues & GH axis · 8 Apr 2026 · 33 likes Injection-site reactions are reported more often in this family than for the incretins. Whether that is the compounds or the preparations they are typically supplied in…
-
GLP-1 receptor distribution: central and peripheral Replied, post #28 · Pharmacology › Receptor biology · 8 Apr 2026 · 9 likes Nothing in receptor biology tells you what is in the vial, which is worth remembering when a mechanistic thread starts being used to justify a sourcing decision. Happy…
-
Packaging that arrived damaged: documenting it properly — a second dataset Replied, post #70 · Sourcing › Logistics · 6 Apr 2026 · 0 likes Split shipments reduce single-point risk and increase the number of transits. Which trade is right depends on what you are protecting against. Written in the hope of…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #72 · Compounds › Tirzepatide · 6 Apr 2026 · 26 likes I had written a reply contradicting post #70 and deleted it. Here is what survived. SURMOUNT-1 reported weight reduction of a magnitude that was the largest for a…
-
Coming back to: Why I now write the concentration on the vial in marker Replied, post #3 · Practice › Reconstitution · 24 Mar 2026 · 12 likes If your arithmetic gives a volume smaller than one graduation on your syringe, the answer is a lower concentration rather than a more careful hand.
-
About the COA interpretation category Replied, post #6 · Analytics › COA interpretation · 17 Mar 2026 · 13 likes Picking up post #3: that is the part I would want checked first. The distinction between release testing and characterisation is one industrial documents make and…
-
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #41 · Outcomes › Body composition · 13 Mar 2026 · 10 likes Lean mass preservation looks different depending on whether you are reading the primary literature or the summaries of it, and the difference is not in our favour.
-
Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #59 · Compounds › Cagrilintide & amylin analogues · 12 Mar 2026 · 0 likes Nothing to add on the substance. Thank you for taking the question at face value.
-
Revisiting: Maintainer handover: how it works Replied, post #46 · Meta › Wiki maintenance · 11 Mar 2026 · 29 likes Marking my place. If it changes for me I will come back and say so.
-
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #2 · Lounge › Introductions · 6 Mar 2026 · 2 likes Welcome: the response to introductions is usually welcome. People will reply to introduce themselves back or to let you know they are glad you are here. It is the sort…
-
Contributing data without breaching anyone's privacy Replied, post #36 · Data & Tools › Datasets · 4 Mar 2026 · 2 likes Date every record. A dataset assembled over two years without dates cannot distinguish a change over time from a change in who was contributing. Reading it again, the…
-
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #120 · Documentation › Wiki requests · 3 Mar 2026 · 0 likes I came in to disagree and I am leaving without a disagreement.
-
Measurement error in a self-reported exposure Replied, post #123 · Evidence › Study critique · 27 Feb 2026 · 14 likes I would put moderate confidence on the mainstream reading of measurement error and no more. That is not scepticism for its own sake; it is where the sourcing actually…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #25 · Compounds › Tirzepatide · 24 Feb 2026 · 30 likes Worth separating two things that post #21 runs together. Titration schedules for tirzepatide have more dose steps than semaglutide partly because the compound is more…
-
What a certificate commits its issuer to — one year on Replied, post #22 · Analytics › COA interpretation · 24 Feb 2026 · 20 likes Post #20 describes the usual case. This is about the unusual one. "Not less than 98 per cent" is a specification. "98.3 per cent" is a result. A certificate carrying…
-
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #81 · Clinical › Bloodwork · 20 Feb 2026 · 0 likes On panel I would separate what is worth knowing from what is worth acting on. The first list is long and the second is short, and conflating them is how threads get…
-
Second pass at: The topic list is dense — is that deliberate? Replied, post #76 · Meta › Site feedback · 19 Feb 2026 · 7 likes Speaking only to topic list as I have actually seen it, rather than as it is usually described: the effect is real, it is smaller than the thread suggests, and the…
-
Mass error in ppm: the arithmetic and the caveat Replied, post #23 · Analytics › Mass spectrometry · 12 Feb 2026 · 19 likes Mass error in parts per million is (observed minus theoretical) divided by theoretical, times a million. On a high-resolution instrument a low single-digit figure is…
-
Second pass at: The topic list is dense — is that deliberate? Replied, post #61 · Meta › Site feedback · 3 Feb 2026 · 0 likes Whatever the answer on topic list turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, invite the correction.
-
Designing a personal experiment that could change your mind Replied, post #5 · Research Methods › N-of-1 designs · 24 Jan 2026 · 27 likes Taking post #4 at face value and following it one step further. The interesting personal experiments are the ones where the answer was no. They are also the ones least…
-
[2026 update] Does a peptide degrade silently, with no visual change? Replied, post #16 · Practice › Storage & stability · 23 Jan 2026 · 0 likes Two sentences on peptide and then I will stop, because the rest is speculation and the thread is better without mine. What is documented is narrow. What is inferred…
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence — the long… Replied, post #61 · Pharmacology › Receptor biology · 16 Jan 2026 · 4 likes Taking post #58 at face value and following it one step further. Bias and desensitisation: receptors can be biased (preferentially activating some downstream pathways…
-
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #34 · Documentation › Wiki requests · 12 Jan 2026 · 24 likes Everything in post #30 holds. The case it does not cover is the one I have. Documents that are mostly a worked example age better than documents that are mostly a…
-
A partial dose because the pen emptied mid-injection Replied, post #43 · Practice › Administration · 8 Jan 2026 · 0 likes A new needle for each injection is not fussiness. A needle blunts on first use and a blunted needle is the reason the second injection hurts more than the first.…
-
[2026 update] Reading a supplementary appendix and finding the interesting part Replied, post #6 · Evidence › Trials · 7 Jan 2026 · 30 likes If someone has run Reading a supplementary appendix properly I would rather read that than my own reconstruction of it. Posting mine only because the thread has gone…
-
Stepping down deliberately, and how to do it without losing progress Replied, post #35 · Practice › Dosing & titration · 31 Dec 2025 · 9 likes Adding the measurement that post #34 says would settle it. Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add…
-
Follow-up: Bug report: the reconstitution calculator and a rounding edge case Replied, post #11 · Data & Tools › Calculators · 28 Dec 2025 · 25 likes Maintaining a calculator means checking the arithmetic against hand-worked cases at each review, not checking that it still loads.
-
Aggregates and why a purity assay may miss them entirely Replied, post #21 · Analytics › Impurities & related substances · 22 Dec 2025 · 8 likes Disulfide formation: if a peptide contains cysteine, it can form disulfide bonds with itself or with other molecules. Under oxidising conditions multiple species…
-
MHRA statements, read directly Replied, post #52 · Regional › UK & Ireland · 20 Dec 2025 · 27 likes Date the claim and say whether it is the United Kingdom or Ireland. They are different regulatory jurisdictions and the answer is frequently different. Someone will…
-
The decimal-point error, and the habit that catches it Replied, post #77 · Practice › Reconstitution · 17 Dec 2025 · 9 likes My understanding of decimal-point error is a few years old and may have been superseded. If it has been, I would genuinely like to know rather than keep repeating it.
-
Personal import allowances, compared — a second dataset Replied, post #36 · Access › International · 15 Dec 2025 · 4 likes I would rather this thread reach "we do not know" about Personal import allowances than reach a confident answer that nobody can support when asked.
-
Promotion criteria, and the one that stops most nominations — the long version Replied, post #109 · Documentation › Doc review · 10 Dec 2025 · 0 likes Adding what did not work for me on Promotion criteria, since the failures never get written up and they are half the useful information.
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #24 · Access › Pricing · 26 Nov 2025 · 27 likes Larger orders shift risk as well as price, because more of your material then comes from one lot. Written in the hope of being told what I have missed.
-
Prescription requirements and telehealth models Replied, post #31 · Sourcing › Regulatory · 25 Nov 2025 · 3 likes Generic or biosimilar entry depends on patent and exclusivity positions that are jurisdiction-specific and are frequently misreported. Adding the caveat now so it does…
-
Realistic expectations for strength while losing weight quickly Replied, post #38 · Nutrition & Training › Resistance training · 22 Nov 2025 · 18 likes Second-hand on realistic expectations for strength, so weight it accordingly — someone whose method I trust told me this and I have not verified it myself.
-
The anatomy of a question that gets answered within an hour — the long version Replied, post #111 · Start Here › How to Ask · 18 Nov 2025 · 15 likes This is the first time the answer has come with its own limits attached. Appreciated.
-
Lurking for two months before posting: was that the right call? Replied, post #8 · Start Here › Welcome · 17 Nov 2025 · 0 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #131 · Practice › Storage & stability · 10 Nov 2025 · 1 like Visible particulate is a strong signal in the other direction: it is a reason to stop and ask rather than to filter and proceed. That has been true for the cases I have…
-
Pen mechanics when the cartridge is nearly empty — does this still hold? Replied, post #10 · Devices › Pens & autoinjectors · 27 Oct 2025 · 1 like Post #9 describes the usual case. This is about the unusual one. A pen that will not dial to the intended dose is usually telling you the cartridge does not contain…
-
Publishing an inconvenient result: a case study — the long version Replied, post #19 · Sourcing › Independent verification · 26 Oct 2025 · 4 likes Repeat testing: if you want to verify the same lot a second time, testing with a different service strengthens the conclusion. Testing with the same service verifies…
-
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #96 · Compounds › Tirzepatide · 23 Oct 2025 · 5 likes Narrowing post #93, because the general version has more than one answer. The five maintenance doses in the tirzepatide programme give a genuine dose-response curve,…
-
Why catalogue breadth is not evidence of anything — what changed since Replied, post #67 · Compounds › Other compounds · 9 Oct 2025 · 23 likes Post #64 is right about the mechanism and I think understates the practical bit. A compound with no established assay is a compound where a certificate can say almost…
-
Hair shedding at month three: mechanism and time course Started this topic · Practice › Side effects · 2 Oct 2025 · 48 likes On the subject in the title: Hair shedding at month three: mechanism and time course Working notes rather than a conclusion. Reading back through what has been written…
-
The nausea timeline across the first four weeks, with a tabulated log Replied, post #103 · Practice › Side effects · 29 Sep 2025 · 0 likes Post #102 answers the question as asked. The question underneath it is different. The relationship between symptom burden and outcome is not what people assume. Feeling…
-
Citing a preprint in a maintained document: our rule and its reasoning — does this still… Replied, post #29 · Evidence › Preprints · 27 Sep 2025 · 4 likes Summarising the Citing a preprint thread so far, since it is long and the answer is buried: the first reply has the method, the fourth has the correction to it, and the…
-
Titles that describe the question, not the situation Replied, post #105 · Start Here › How to Ask · 25 Sep 2025 · 0 likes I disagree with the framing of titles above, and I think it is a substantive disagreement rather than a terminological one. Setting out why, so it can be checked. The…
-
Reading an interaction checker output critically Replied, post #10 · Practice › Interactions · 24 Sep 2025 · 4 likes A supplement is a drug for interaction purposes, and the fact that it is sold without a prescription tells you nothing about whether it interacts. The paperwork is…
-
Semaglutide versus liraglutide head to head: reading STEP 8 carefully Replied, post #61 · Compounds › Semaglutide · 19 Sep 2025 · 4 likes Post #60 is right about the mechanism and I think understates the practical bit. Injection site does not appear to matter much for semaglutide exposure. The published…
-
Promotion criteria, and the one that stops most nominations — the long version Replied, post #57 · Documentation › Doc review · 14 Sep 2025 · 2 likes Posting my Promotion criteria numbers with the method attached so they can be discounted properly. Uncontrolled, unblinded, and collected by someone who wanted a…
-
"Should I double up?" — answered once, at length, calmly Replied, post #17 · Practice › Administration · 10 Sep 2025 · 25 likes Air bubbles in a subcutaneous injection: the honest risk assessment is low. Tiny air bubbles in subcutaneous tissue do not behave like an air embolism in a blood…
-
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #11 · Compounds › Semaglutide · 28 Aug 2025 · 24 likes The opalescent appearance in semaglutide solutions is occasionally noted and the mechanism is unclear. It does not appear to correlate with product failure in practice.…
-
[2026 update] A single out-of-range value on an otherwise normal panel Replied, post #6 · marked as the solution · Clinical › Bloodwork · 20 Aug 2025 · 10 likes Time of day: some biomarkers vary across the day. Cortisol in the morning differs from cortisol in the evening. Comparing results from different times of day is…
-
Power cut for eleven hours: how I assessed it afterwards Replied, post #20 · Practice › Storage & stability · 11 Aug 2025 · 0 likes Visible particulate is a strong signal in the other direction: it is a reason to stop and ask rather than to filter and proceed.
-
Coming back to: Official shortage notices and what they authorise Replied, post #83 · Access › Shortages · 8 Aug 2025 · 0 likes Before the thread moves on from Official shortage notices — what is the sample size behind the claim? I am not being difficult; I have seen the same figure quoted from…
-
Semaglutide versus liraglutide head to head: reading STEP 8 carefully Replied, post #36 · Compounds › Semaglutide · 3 Aug 2025 · 0 likes Injection site does not appear to matter much for semaglutide exposure. The published comparisons of abdomen, thigh and upper arm found differences small enough to be…
-
Revisiting: Review: an evidence digest and the citation check that delayed it Replied, post #3 · marked as the solution · Documentation › Doc review · 28 Jul 2025 · 12 likes The opening post and I disagree about the size of the effect, not about the direction. Review date disputes: if a maintained page's review date is approaching and it…
-
Comparing tirzepatide and semaglutide is harder than the tables suggest Replied, post #2 · Compounds › Tirzepatide · 24 Jul 2025 · 19 likes Understood. Thank you for being specific about the limits of it.
-
Counter-ion content and its effect on measured mass Replied, post #99 · Analytics › Mass spectrometry · 22 Jul 2025 · 6 likes Purity and identity are different questions: LC-MS establishes that the species at a retention time has the expected mass. It does not establish how much of the sample…
-
What the GIP component of tirzepatide is thought to contribute, and how confident we can… Replied, post #7 · Compounds › Tirzepatide · 22 Jun 2025 · 27 likes The dual agonism is not a marketing framing — GIP receptor and GLP-1 receptor engagement are both demonstrable. What is genuinely unresolved is how much of the clinical…
-
High-resolution MS on aggregates and what it can see Replied, post #8 · Analytics › Mass spectrometry · 19 Jun 2025 · 0 likes Adding a small correction to the high-resolution summary above rather than a disagreement with it. The substance holds; one of the figures is out by a factor that…
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #123 · Devices › Cold chain · 15 Jun 2025 · 11 likes That is a cleaner way of putting what I was circling around.
-
Micronutrient status when intake falls substantially Replied, post #10 · Clinical › Bloodwork · 11 Jun 2025 · 3 likes Post #9 put the caveat in the right place and I want to underline it. Two questions I would want answered before drawing anything from the micronutrient status data…
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #24 · Access › Insurance & coverage · 8 Jun 2025 · 13 likes Denial letters: the stated reason tells you exactly what to submit next. A denial is not final; it is a specification for an appeal. Reading the reason carefully and…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — what changed since Replied, post #86 · Practice › Reconstitution · 7 Jun 2025 · 27 likes Where I part company with post #82, and it is a narrow parting. Where the 5 mg vial reasoning breaks down for me is the step from the group result to the individual…
-
How to bring a laboratory report to an appointment usefully Replied, post #3 · Clinical › Bloodwork · 6 Jun 2025 · 26 likes The most useful thing this subcategory does is help people tell an interesting result from an uninteresting one before booking an appointment about it. That is all the…
-
Albumin binding and how it produces a long half-life Replied, post #45 · Pharmacology › Pharmacokinetics · 6 Jun 2025 · 0 likes Steady state is approached in roughly four to five half-lives. For a compound with a week-long half-life that is four to five weeks, which is where the escalation…
-
Second pass at: Semaglutide and alcohol: what is actually documented Replied, post #9 · Compounds › Semaglutide · 3 Jun 2025 · 0 likes Following, with nothing to contribute beyond having asked the same thing elsewhere.
-
Titles that describe the question, not the situation Replied, post #20 · Start Here › How to Ask · 1 Jun 2025 · 12 likes Worth separating two things that post #18 runs together. If your question has a deadline — a parcel in transit, a delivery you have to accept or refuse — say so. People…
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #112 · Devices › Cold chain · 28 May 2025 · 0 likes I read the earlier replies on Domestic fridge temperature mapping twice before writing this, because I had assumed the opposite and wanted to be sure I was disagreeing…
-
Revisiting: Why I ask for the gradient before I discuss the number Replied, post #7 · Analytics › HPLC & UHPLC · 27 May 2025 · 24 likes System suitability testing: injections run before and during the sample run to establish whether the instrument, column and method were performing when the sample was…
-
Lean mass preservation: what the evidence supports Replied, post #4 · Outcomes › Body composition · 5 May 2025 · 0 likes I would keep lean mass preservation and the decision it usually gets used for separate in this thread. They are related and they are not the same question, and merging…
-
Semaglutide versus liraglutide head to head: reading STEP 8 carefully Started this topic · Compounds › Semaglutide · 3 May 2025 · 21 likes On the subject in the title: Semaglutide versus liraglutide head to head: reading STEP 8 carefully Working notes rather than a conclusion. I would like to disagree…
-
A claim built entirely on a subgroup analysis Replied, post #13 · Evidence › Study critique · 1 May 2025 · 0 likes Bias towards the null and bias away from the null: different criticisms have different directions. Differential dropout might bias away from null; conservative…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #93 · Practice › Reconstitution · 30 Apr 2025 · 26 likes I had written a reply contradicting post #91 and deleted it. Here is what survived. How much of the diluent volume the powder itself displaces: for a small peptide…
-
Why we hide unevidenced fraud accusations and log the hiding Replied, post #86 · Sourcing › Red flags · 26 Apr 2025 · 1 like The strongest single signal available cheaply is what happens when you ask a technical question. A quantitative answer inside a working day is difficult to fake at scale.
-
Second pass at: Pen dose counters: what a click does and does not guarantee Replied, post #21 · Devices › Pens & autoinjectors · 18 Apr 2025 · 13 likes Post #19 and I disagree about the size of the effect, not about the direction. The click count on a dialled pen is a mechanical property of that pen and is not a…
-
Cost per milligram, computed honestly across formats — the long version Replied, post #67 · Access › Pricing · 16 Apr 2025 · 12 likes Post #66 and I disagree about the size of the effect, not about the direction. Pharmacy acquisition cost: a pharmacy pays less than the patient pays, even at insurance…
-
A certificate with no method stated: what can you conclude? Replied, post #24 · Analytics › COA interpretation · 3 Apr 2025 · 0 likes Post #22 answers the question as asked. The question underneath it is different. A certificate of analysis is a statement by its issuer that a defined test was…
-
Reading order for a first week here, and what to skip until later Replied, post #47 · Start Here › Welcome · 22 Mar 2025 · 1 like Reading counts toward trust level, so lurking is not wasted. That is unusual and it is the reason the levels here track familiarity rather than volume.
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #4 · Sourcing › Vendor reports · 14 Mar 2025 · 31 likes Photograph the vial and the label before opening. It costs ten seconds and it is what turns a report into something checkable.
-
Albumin binding and how it produces a long half-life Replied, post #12 · Pharmacology › Pharmacokinetics · 7 Mar 2025 · 1 like Half-life determines how quickly concentration approaches steady state and does not determine what the steady-state concentration is. Dose and clearance determine that.…
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #65 · Sourcing › Regulatory · 2 Mar 2025 · 0 likes I read post #63 twice before replying, because I had assumed the opposite. I have no financial interest in anything named in this thread and I want to say so before I…
-
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #72 · Access › International · 1 Mar 2025 · 3 likes Adding a small correction to the Cross-border purchase within summary above rather than a disagreement with it. The substance holds; one of the figures is out by a…
-
Assessing a warm arrival: the decision process Replied, post #7 · Sourcing › Logistics · 26 Feb 2025 · 0 likes Cold packs and temperature control: inclusion of cold packs at despatch is standard. Whether they maintain temperature through transit depends on journey duration and…
-
Individual participant data versus aggregate data Replied, post #20 · Evidence › Meta-analyses · 25 Feb 2025 · 4 likes Adding the measurement that post #17 says would settle it. Individual participant data pooling is a much stronger design than aggregate pooling and is rare because it…
-
Revisiting: Aggregate verification data across the directory, with caveats Replied, post #12 · Sourcing › Independent verification · 19 Feb 2025 · 0 likes Repeat determination on the same product line months apart is the measurement that speaks to consistency, and consistency is what most buyers actually want. That has…
-
Reading order for a first week here, and what to skip until later Replied, post #9 · Start Here › Welcome · 19 Feb 2025 · 0 likes Distinguishing three things in the reading order discussion that keep getting used interchangeably: the observation, the proposed mechanism, and the recommendation that…
-
Distinguishing a deletion sequence by mass alone Replied, post #78 · Analytics › Mass spectrometry · 12 Feb 2025 · 33 likes Adducts — sodium and potassium especially — shift the observed mass in predictable increments. A report showing an unexplained plus twenty-two is usually showing you a…
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #76 · Sourcing › Regulatory · 2 Feb 2025 · 0 likes One caution on Research-use-only labelling: everything above assumes the underlying documentation is what it claims to be. That assumption is doing real work and is…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #5 · Compounds › Tirzepatide · 14 Jan 2025 · 0 likes Worth separating two things that post #3 runs together. Mass and charge states: tirzepatide is about 4813.5 Da and on an electrospray instrument you would expect to see…
-
Coming back to: Reading a meta-analysis you disagree with, fairly Replied, post #13 · Evidence › Meta-analyses · 1 Jan 2025 · 6 likes This follows post #10 rather than contradicting it. Where I would push back on the Reading a meta-analysis consensus is the confidence, not the direction. The direction…
-
Body image changing more slowly than the body Replied, post #94 · Wellbeing › Mental health · 21 Dec 2024 · 24 likes Worth separating two things that post #90 runs together. Identity and self-image: for some people, weight and body size are central to identity. Large change to body…
-
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #44 · Compounds › Semaglutide · 21 Dec 2024 · 7 likes On alcohol: the labelling does not contraindicate it, but it raises gastric irritation risk and semaglutide already does that. There is no published interaction study…
-
Injection-site reactions: describing them precisely enough to be useful Replied, post #73 · Practice › Side effects · 14 Dec 2024 · 1 like Appreciated. The plain phrasing does more work here than a longer post would.
-
TB-500 and thymosin beta-4: the fragment versus the protein — does this still hold? Replied, post #15 · Compounds › Repair & healing peptides · 9 Dec 2024 · 0 likes Coming back to post #13, because the follow-up matters more than the original answer. Before the thread moves on from TB-500 and thymosin beta-4 — what is the sample…
-
[2026 update] New subcategory: rationale and scope Replied, post #51 · Meta › Announcements · 8 Dec 2024 · 31 likes Adding the measurement that post #48 says would settle it. New subcategory was covered in the wiki last year and the page has a review date on it, which is a better…
-
Reading a supplementary appendix and finding the interesting part Replied, post #39 · Evidence › Trials · 8 Dec 2024 · 20 likes Reframing reading a supplementary appendix slightly, because I think the disagreement is about the question rather than the answer. If the question is "does it happen",…
-
What we do not know about retatrutide, listed explicitly Replied, post #5 · Compounds › Retatrutide · 25 Nov 2024 · 2 likes Triple agonism: is the effect additive, synergistic, or neither? A phase 2 comparison of tirzepatide (dual) to retatrutide (triple) would answer that question. The…
-
Athletes in weight-category sports: a different risk calculus — a second dataset Replied, post #16 · Clinical › Special populations · 13 Nov 2024 · 1 like Fine by me. I had wanted a stronger conclusion and there is not one available.
-
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #40 · Compounds › Other compounds · 9 Oct 2024 · 0 likes Confirming post #39 from a second method, which matters more than confirming it from a second person. Thymosin alpha-1 has a regulatory history in several jurisdictions…
-
Anxiety in the first weeks: drug, situation, or both Replied, post #5 · Wellbeing › Mental health · 2 Oct 2024 · 19 likes The failure mode on anxiety is boring rather than dramatic. It is almost always the step everyone assumes was done correctly because it is too simple to get wrong.
-
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #100 · Sourcing › Independent verification · 1 Oct 2024 · 0 likes It does not extend to lots nobody has seen, it is not a recommendation, and it says nothing about anything other than what was measured. That distinction has done more…
-
The topic list is dense — is that deliberate? Replied, post #29 · Meta › Site feedback · 23 Sep 2024 · 22 likes The thing about topic list that took me longest to accept is that a plausible mechanism is not evidence of an effect. It is a reason to look, not a result.
-
Research-use-only labelling: what it means and what it does not — the long version Started this topic · Sourcing › Regulatory · 15 Sep 2024 · 0 likes Posting this under the heading it deserves: Research-use-only labelling: what it means and what it does not — the long version Everything below is what sits behind…
-
A rising related-substance total over six months: degradation or method drift? Replied, post #18 · Analytics › Impurities & related substances · 30 Aug 2024 · 9 likes Related substances: compounds chemically related to the target peptide but not the target peptide itself. The standard method separates them and reports them as area…
-
Coming back to: The nausea timeline across the first four weeks, with a tabulated log Replied, post #8 · Practice › Side effects · 14 Aug 2024 · 7 likes I had written a reply contradicting post #6 and deleted it. Here is what survived. A symptom that starts weeks after a dose has been stable is a different observation…
-
Follow-up: What this community means by "a source", in practical terms Replied, post #2 · Start Here › Welcome · 29 Jul 2024 · 0 likes Nothing to add on the substance. Thank you for taking the question at face value.
-
Where the four-week escalation interval comes from, and what it is not Replied, post #28 · Practice › Dosing & titration · 23 Jun 2024 · 0 likes That is consistent with mine, for whatever one more account is worth.
-
Spreadsheets: an appreciation Replied, post #12 · Lounge › Off topic · 6 Jun 2024 · 6 likes Distinguishing three things in the spreadsheets discussion that keep getting used interchangeably: the observation, the proposed mechanism, and the recommendation that…